Caseware UK (AP4) 2023.0.135 2023.0.135 2024-01-312024-01-31truetrue2023-02-01falseNo description of principal activity00The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09951386 2023-02-01 2024-01-31 09951386 2022-02-01 2023-01-31 09951386 2024-01-31 09951386 2023-01-31 09951386 c:Director2 2023-02-01 2024-01-31 09951386 d:FurnitureFittings 2023-02-01 2024-01-31 09951386 d:FurnitureFittings 2024-01-31 09951386 d:FurnitureFittings 2023-01-31 09951386 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-02-01 2024-01-31 09951386 d:CurrentFinancialInstruments 2024-01-31 09951386 d:CurrentFinancialInstruments 2023-01-31 09951386 d:CurrentFinancialInstruments d:WithinOneYear 2024-01-31 09951386 d:CurrentFinancialInstruments d:WithinOneYear 2023-01-31 09951386 d:ShareCapital 2024-01-31 09951386 d:ShareCapital 2023-01-31 09951386 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-01-31 09951386 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-01-31 09951386 c:FRS102 2023-02-01 2024-01-31 09951386 c:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 09951386 c:FullAccounts 2023-02-01 2024-01-31 09951386 c:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 09951386 2 2023-02-01 2024-01-31 iso4217:GBP xbrli:pure

Registered number: 09951386









OPHTHALMICORP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

 
OPHTHALMICORP LIMITED
REGISTERED NUMBER: 09951386

BALANCE SHEET
AS AT 31 JANUARY 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
462
616

  
462
616

Current assets
  

Debtors: amounts falling due within one year
 5 
2,157
2,398

Cash at bank and in hand
 6 
15,532
12,496

  
17,689
14,894

Creditors: amounts falling due within one year
 7 
(18,149)
(15,508)

Net current liabilities
  
 
 
(460)
 
 
(614)

Total assets less current liabilities
  
2
2

  

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
  
2
2

  
2
2

Page 1

 
OPHTHALMICORP LIMITED
REGISTERED NUMBER: 09951386
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 September 2024.




................................................
Joshua Owen Thomas
Director

The notes on pages 3 to 6 form part of these financial statements.
Page 2

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

1.


General information

The Company is a private company limited by shares, incorporated in England. The principal activity throughout the year was the provision of administrative, managerial, marketing and financial services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 3

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

3.


Employees

The Company has no employees other than the directors, who did not receive any remuneration (2023 - £NIL).


4.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 February 2023
3,459



At 31 January 2024

3,459



Depreciation


At 1 February 2023
2,843


Charge for the year on owned assets
154



At 31 January 2024

2,997



Net book value



At 31 January 2024
462



At 31 January 2023
616

Page 5

 
OPHTHALMICORP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

5.


Debtors

2024
2023
£
£


Amounts owed by joint ventures and associated undertakings
1,964
2,199

Other debtors
2
2

Prepayments and accrued income
191
197

2,157
2,398



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
15,532
12,496

15,532
12,496



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
16,649
11,789

Other creditors
-
3,719

Accruals and deferred income
1,500
-

18,149
15,508



8.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
15,532
12,496




Financial assets measured at fair value through profit or loss comprise cash at bank and in hand.


9.


Controlling party

There is no overall controlling party.
Page 6

 
OPHTHALMICORP LIMITED
 
 
 Page 7